Cummings Announces Hearing With ONDCP Director on New White House Drug Strategy
Washington, D.C. (Feb. 1, 2019)—Today, Rep. Elijah E. Cummings, the Chairman of the Committee on Oversight and Reform, announced that James Carroll, the Director of the Office of National Drug Control Policy (ONDCP), has agreed to testify at a hearing on February 12, 2019. The hearing will cover President Trump’s first-ever National Drug Control Strategy, which the White House released yesterday.
In announcing the hearing, Chairman Cummings issued the following statement:
“I thank Director Carroll for agreeing to testify before our Committee on the opioid crisis, which is devastating American families in red states, blue states, and purple states. It truly is a national epidemic, and we need a national response. Unfortunately, the Trump Administration did not have a strategy in place to deal with this epidemic over the past two years. Although I am encouraged that the White House has finally put out its long overdue plan, I am very concerned that this strategy fails to identify additional resources to make treatment available for many who desperately need it, fails to identify quantifiable and measurable objectives and goals, and—in my opinion—fails to address the gravity of the generational crisis our nation now faces.”
The hearing will be held at 10 a.m. on Tuesday, February 12, 2019.